Article Listing - Sanofi-Synthelabo sells Arixtra and Fraxiparine to GSK for 453M euros
NEW YORK MEETINGS
10 February 1992
Two industry-related meetings are due to be held soon at the Loews Summit Hotel, New York: Cost Containment and Quality...
FEMALE CONDOM RECOMMENDED FOR USA
10 February 1992
The Obstetrics and Gynec-ology Devices Advisory Commit-tee of the US Food and Drug Administration has recommended approval of Chartex Inter-national's...
EC "BLOW" TO NEW OTC PRODUCTS
10 February 1992
As it now stands, the Commission of the European Communities' proposed directive on advertising of over-the counter products in the...
INDUSTRY RESPONSE TO JAPAN DRUG PRICE MOVES
10 February 1992
The Koseisho, Japan's Ministry of Health and Welfare, is in the process of clarifying how it intends to implement the...
"KEY" US PATENT FOR BIOPURE'S HEMOPURE
10 February 1992
Boston, Massachusetts-based start-up company Biopure Corp reports that it has received a US patent covering its novel blood substitute Hemopure,...
GOOD YEAR FOR SANOFI IN 1991
10 February 1992
In 1991 sales at the French health and beauty concern, Elf Sanofi, increased 5.8% to 19.6 billion French francs ($3.6...
PFIZER PLANS NEW UNIT IN USA
10 February 1992
US pharmaceutical concern Pfizer is setting up a new unit at its Groton plant in the USA.The company has...
END OF FRENCH BLOC ON NEW DRUG INTROS
3 February 1992
The French government has agreed to renew the commission which gives advice to the Health Minister on drug-price fixing for...
WYETH AYERST/ TLC FLU VACCINE DEAL
3 February 1992
Wyeth-Ayerst Laboratories, a division of American Home Products, has entered into an agreement with The Liposome Company concerning the development...
STOCK MARKET COMMENTARY: TOKYO
3 February 1992
TOKYO: closed with a 0.4% gain at 21,007.11 yen after a volatile trading week dominated by index and futures- linked...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
